Substitution instrument to address shortage of abatacept

The Therapeutic Goods Administration (TGA) has been notified of shortages of multiple presentations of abatacept (Orencia) products due to

Related Keywords

,Therapeutic Goods Administration ,Serious Scarcity Substitution Instrument ,Therapeutic Goods ,Serious Scarcity ,Substitutable Medicine ,